Evotec SE (EVOTF)
OTCMKTS
· Delayed Price · Currency is USD
8.27
-0.95 (-10.29%)
At close: Jan 21, 2025
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$178,755
Profits / Employee
-$46,940
Market Cap
1.42B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Evotec SE News
- 14 days ago - Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments - Accesswire
- 15 days ago - Evotec SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 15 days ago - Evotec SE (EVO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment - Accesswire
- 15 days ago - Earnings Preview: Evotec - Benzinga
- 22 days ago - Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 - Accesswire
- 27 days ago - Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb - Accesswire
- 4 weeks ago - Evotec SE (EVO) Q4 2024 Earnings Call Transcript - Seeking Alpha